December 20, 2024 07:00 AM EST
Deals
Diagnostics

Trac­er Biotech­nolo­gies rais­es $10M, part­ners with As­traZeneca

Jared Whitlock

Features Editor

Trac­er Biotech­nolo­gies has raised a $10 mil­lion Se­ries A round to ad­vance its tech­nol­o­gy that’s de­signed to mon­i­tor cir­cu­lat­ing tu­mor DNA in can­cer pa­tients over …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

Ap­plied Ther­a­peu­tics CEO steps down af­ter rare dis­ease drug re­jec­tion

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

FDA ap­proves Io­n­is’ treat­ment for a rare meta­bol­ic dis­or­der

A service from the Financial Times